サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1119608

世界の内分泌検査市場：考察と予測 (2028年まで)

Global Endocrine Testing Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 117 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
世界の内分泌検査市場：考察と予測 (2028年まで)
出版日: 2022年08月29日
発行: QYResearch
ページ情報: 英文 117 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、内分泌検査 (Endocrine Testing) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の内分泌検査の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Tandem Mass Spectrometry
    • Immunoassay
  • 市場：アプリケーション別
    • 世界の内分泌検査の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Hospitals
    • Commercial Laboratories
    • Ambulatory Care Centres
    • Other Setting
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の内分泌検査の市場展望 (2017-2028)
  • 内分泌検査の市場成長トレンド：地域別
    • 内分泌検査 市場規模：地域別: 2017 VS 2021 VS 2028
    • 内分泌検査の市場規模実績：地域別 (2017-2022)
    • 内分泌検査の市場規模予測：地域別 (2023-2028)
  • 内分泌検査 市場動向
    • 内分泌検査 業界動向
    • 内分泌検査 市場の促進要因
    • 内分泌検査 市場の課題
    • 内分泌検査 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の内分泌検査の上位企業：収益別
    • 世界の内分泌検査の上位企業：収益別 (2017-2022)
    • 世界の内分泌検査の収益シェア：企業別 (2017-2022)
  • 世界の内分泌検査の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：内分泌検査の収益
  • 世界の内分泌検査 市場集中度
    • 世界の内分泌検査 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 内分泌検査の収益 2021
  • 内分泌検査の主要企業の本社および事業エリア
  • 主要企業 内分泌検査の製品ソリューションおよびサービス
  • 市場参入時期： 内分泌検査 市場
  • M&A, 拡張計画

第4章 内分泌検査 内訳データ：タイプ別

  • 世界の内分泌検査の市場規模実績：タイプ別 (2017-2022)
  • 世界の内分泌検査の市場規模予測：タイプ別 (2023-2028)

第5章 内分泌検査 内訳データ：アプリケーション別

  • 世界の内分泌検査の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の内分泌検査の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の内分泌検査 市場規模 (2017-2028)
  • 北米の内分泌検査 市場規模：タイプ別
    • 北米の内分泌検査 市場規模：タイプ別 (2017-2022)
    • 北米の内分泌検査 市場規模：タイプ別 (2023-2028)
    • 北米の内分泌検査の市場シェア：タイプ別 (2017-2028)
  • 北米の内分泌検査 市場規模：アプリケーション別
    • 北米の内分泌検査 市場規模：アプリケーション別 (2017-2022)
    • 北米の内分泌検査 市場規模：アプリケーション別 (2023-2028)
    • 北米の内分泌検査の市場シェア：アプリケーション別 (2017-2028)
  • 北米の内分泌検査 市場規模：国別
    • 北米の内分泌検査 市場規模：国別 (2017-2022)
    • 北米の内分泌検査 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の内分泌検査 市場規模 (2017-2028)
  • 欧州の内分泌検査 市場規模：タイプ別
    • 欧州の内分泌検査 市場規模：タイプ別 (2017-2022)
    • 欧州の内分泌検査 市場規模：タイプ別 (2023-2028)
    • 欧州の内分泌検査の市場シェア：タイプ別 (2017-2028)
  • 欧州の内分泌検査 市場規模：アプリケーション別
    • 欧州の内分泌検査 市場規模：アプリケーション別 (2017-2022)
    • 欧州の内分泌検査 市場規模：アプリケーション別 (2023-2028)
    • 欧州の内分泌検査の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の内分泌検査 市場規模：国別
    • 欧州の内分泌検査 市場規模：国別 (2017-2022)
    • 欧州の内分泌検査 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 内分泌検査 市場規模 (2017-2028)
  • アジア太平洋地域 内分泌検査 市場規模：タイプ別
    • アジア太平洋地域 内分泌検査 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 内分泌検査 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 内分泌検査の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 内分泌検査 市場規模：アプリケーション別
    • アジア太平洋地域 内分泌検査 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 内分泌検査 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 内分泌検査の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 内分泌検査 市場規模：地域別
    • アジア太平洋地域 内分泌検査 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 内分泌検査 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの内分泌検査 市場規模 (2017-2028)
  • ラテンアメリカの内分泌検査 市場規模：タイプ別
    • ラテンアメリカの内分泌検査 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの内分泌検査 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの内分泌検査の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの内分泌検査 市場規模：アプリケーション別
    • ラテンアメリカの内分泌検査 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの内分泌検査 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの内分泌検査の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの内分泌検査 市場規模：国別
    • ラテンアメリカの内分泌検査 市場規模：国別 (2017-2022)
    • ラテンアメリカの内分泌検査 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの内分泌検査 市場規模 (2017-2028)
  • 中東・アフリカの内分泌検査 市場規模：タイプ別
    • 中東・アフリカの内分泌検査 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの内分泌検査 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの内分泌検査の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの内分泌検査 市場規模：アプリケーション別
    • 中東・アフリカの内分泌検査 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの内分泌検査 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの内分泌検査の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの内分泌検査 市場規模：国別
    • 中東・アフリカの内分泌検査 市場規模：国別 (2017-2022)
    • 中東・アフリカの内分泌検査 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Abbott Laboratories
  • AdnaGen
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • Dako
  • DiaSorin
  • Eiken
  • Fujirebio
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Endocrine Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Tandem Mass Spectrometry
  • Table 3. Key Players of Immunoassay
  • Table 4. Global Endocrine Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Endocrine Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Endocrine Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Endocrine Testing Market Share by Region (2017-2022)
  • Table 8. Global Endocrine Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Endocrine Testing Market Share by Region (2023-2028)
  • Table 10. Endocrine Testing Market Trends
  • Table 11. Endocrine Testing Market Drivers
  • Table 12. Endocrine Testing Market Challenges
  • Table 13. Endocrine Testing Market Restraints
  • Table 14. Global Endocrine Testing Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Endocrine Testing Revenue Share by Players (2017-2022)
  • Table 16. Global Top Endocrine Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Testing as of 2021)
  • Table 17. Ranking of Global Top Endocrine Testing Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Endocrine Testing Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Endocrine Testing Product Solution and Service
  • Table 21. Date of Enter into Endocrine Testing Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Endocrine Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Endocrine Testing Revenue Market Share by Type (2017-2022)
  • Table 25. Global Endocrine Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Endocrine Testing Revenue Market Share by Type (2023-2028)
  • Table 27. Global Endocrine Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Endocrine Testing Revenue Share by Application (2017-2022)
  • Table 29. Global Endocrine Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Endocrine Testing Revenue Share by Application (2023-2028)
  • Table 31. North America Endocrine Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Endocrine Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Endocrine Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Endocrine Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Endocrine Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Endocrine Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Endocrine Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Endocrine Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Endocrine Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Endocrine Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Endocrine Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Endocrine Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Endocrine Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Endocrine Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Endocrine Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Endocrine Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Endocrine Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Endocrine Testing Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Endocrine Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Endocrine Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Endocrine Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Endocrine Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Endocrine Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Endocrine Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Endocrine Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Endocrine Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Endocrine Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Endocrine Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Endocrine Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Endocrine Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Abbott Laboratories Company Details
  • Table 62. Abbott Laboratories Business Overview
  • Table 63. Abbott Laboratories Endocrine Testing Product
  • Table 64. Abbott Laboratories Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 65. Abbott Laboratories Recent Developments
  • Table 66. AdnaGen Company Details
  • Table 67. AdnaGen Business Overview
  • Table 68. AdnaGen Endocrine Testing Product
  • Table 69. AdnaGen Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 70. AdnaGen Recent Developments
  • Table 71. Beckman Coulter/Danaher Company Details
  • Table 72. Beckman Coulter/Danaher Business Overview
  • Table 73. Beckman Coulter/Danaher Endocrine Testing Product
  • Table 74. Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 75. Beckman Coulter/Danaher Recent Developments
  • Table 76. Biomedical Diagnostics Company Details
  • Table 77. Biomedical Diagnostics Business Overview
  • Table 78. Biomedical Diagnostics Endocrine Testing Product
  • Table 79. Biomedical Diagnostics Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 80. Biomedical Diagnostics Recent Developments
  • Table 81. BioMerieux Company Details
  • Table 82. BioMerieux Business Overview
  • Table 83. BioMerieux Endocrine Testing Product
  • Table 84. BioMerieux Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 85. BioMerieux Recent Developments
  • Table 86. Bio-Rad Company Details
  • Table 87. Bio-Rad Business Overview
  • Table 88. Bio-Rad Endocrine Testing Product
  • Table 89. Bio-Rad Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 90. Bio-Rad Recent Developments
  • Table 91. Dako Company Details
  • Table 92. Dako Business Overview
  • Table 93. Dako Endocrine Testing Product
  • Table 94. Dako Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 95. Dako Recent Developments
  • Table 96. DiaSorin Company Details
  • Table 97. DiaSorin Business Overview
  • Table 98. DiaSorin Endocrine Testing Product
  • Table 99. DiaSorin Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 100. DiaSorin Recent Developments
  • Table 101. Eiken Company Details
  • Table 102. Eiken Business Overview
  • Table 103. Eiken Endocrine Testing Product
  • Table 104. Eiken Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 105. Eiken Recent Developments
  • Table 106. Fujirebio Company Details
  • Table 107. Fujirebio Business Overview
  • Table 108. Fujirebio Endocrine Testing Product
  • Table 109. Fujirebio Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 110. Fujirebio Recent Developments
  • Table 111. Instrumentation Laboratory Company Details
  • Table 112. Instrumentation Laboratory Business Overview
  • Table 113. Instrumentation Laboratory Endocrine Testing Product
  • Table 114. Instrumentation Laboratory Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 115. Instrumentation Laboratory Recent Developments
  • Table 116. Kyowa Medex Company Details
  • Table 117. Kyowa Medex Business Overview
  • Table 118. Kyowa Medex Endocrine Testing Product
  • Table 119. Kyowa Medex Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 120. Kyowa Medex Recent Developments
  • Table 121. Matritech Company Details
  • Table 122. Matritech Business Overview
  • Table 123. Matritech Endocrine Testing Product
  • Table 124. Matritech Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 125. Matritech Recent Developments
  • Table 126. Ortho-Clinical Diagnostics Company Details
  • Table 127. Ortho-Clinical Diagnostics Business Overview
  • Table 128. Ortho-Clinical Diagnostics Endocrine Testing Product
  • Table 129. Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 130. Ortho-Clinical Diagnostics Recent Developments
  • Table 131. Roche Company Details
  • Table 132. Roche Business Overview
  • Table 133. Roche Endocrine Testing Product
  • Table 134. Roche Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 135. Roche Recent Developments
  • Table 136. Siemens Company Details
  • Table 137. Siemens Business Overview
  • Table 138. Siemens Endocrine Testing Product
  • Table 139. Siemens Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 140. Siemens Recent Developments
  • Table 141. Sysmex Company Details
  • Table 142. Sysmex Business Overview
  • Table 143. Sysmex Endocrine Testing Product
  • Table 144. Sysmex Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 145. Sysmex Recent Developments
  • Table 146. Thermo Fisher Company Details
  • Table 147. Thermo Fisher Business Overview
  • Table 148. Thermo Fisher Endocrine Testing Product
  • Table 149. Thermo Fisher Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 150. Thermo Fisher Recent Developments
  • Table 151. Tosoh Company Details
  • Table 152. Tosoh Business Overview
  • Table 153. Tosoh Endocrine Testing Product
  • Table 154. Tosoh Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 155. Tosoh Recent Developments
  • Table 156. Wako Company Details
  • Table 157. Wako Business Overview
  • Table 158. Wako Endocrine Testing Product
  • Table 159. Wako Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 160. Wako Recent Developments
  • Table 161. Wallac/PE Company Details
  • Table 162. Wallac/PE Business Overview
  • Table 163. Wallac/PE Endocrine Testing Product
  • Table 164. Wallac/PE Revenue in Endocrine Testing Business (2017-2022) & (US$ Million)
  • Table 165. Wallac/PE Recent Developments
  • Table 166. Research Programs/Design for This Report
  • Table 167. Key Data Information from Secondary Sources
  • Table 168. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Endocrine Testing Market Share by Type: 2021 VS 2028
  • Figure 2. Tandem Mass Spectrometry Features
  • Figure 3. Immunoassay Features
  • Figure 4. Global Endocrine Testing Market Share by Application: 2021 VS 2028
  • Figure 5. Hospitals Case Studies
  • Figure 6. Commercial Laboratories Case Studies
  • Figure 7. Ambulatory Care Centres Case Studies
  • Figure 8. Other Setting Case Studies
  • Figure 9. Endocrine Testing Report Years Considered
  • Figure 10. Global Endocrine Testing Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global Endocrine Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Endocrine Testing Market Share by Region: 2021 VS 2028
  • Figure 13. Global Endocrine Testing Market Share by Players in 2021
  • Figure 14. Global Top Endocrine Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Testing as of 2021)
  • Figure 15. The Top 10 and 5 Players Market Share by Endocrine Testing Revenue in 2021
  • Figure 16. North America Endocrine Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 17. North America Endocrine Testing Market Size Market Share by Type (2017-2028)
  • Figure 18. North America Endocrine Testing Market Size Market Share by Application (2017-2028)
  • Figure 19. North America Endocrine Testing Market Size Share by Country (2017-2028)
  • Figure 20. United States Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Europe Endocrine Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Endocrine Testing Market Size Market Share by Type (2017-2028)
  • Figure 24. Europe Endocrine Testing Market Size Market Share by Application (2017-2028)
  • Figure 25. Europe Endocrine Testing Market Size Share by Country (2017-2028)
  • Figure 26. Germany Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. France Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. U.K. Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Italy Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Russia Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Nordic Countries Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Endocrine Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 33. Asia Pacific Endocrine Testing Market Size Market Share by Type (2017-2028)
  • Figure 34. Asia Pacific Endocrine Testing Market Size Market Share by Application (2017-2028)
  • Figure 35. Asia Pacific Endocrine Testing Market Size Share by Region (2017-2028)
  • Figure 36. China Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Japan Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. South Korea Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Southeast Asia Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. India Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Australia Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 42. Latin America Endocrine Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 43. Latin America Endocrine Testing Market Size Market Share by Type (2017-2028)
  • Figure 44. Latin America Endocrine Testing Market Size Market Share by Application (2017-2028)
  • Figure 45. Latin America Endocrine Testing Market Size Share by Country (2017-2028)
  • Figure 46. Mexico Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Brazil Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Middle East & Africa Endocrine Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 49. Middle East and Africa Endocrine Testing Market Size Market Share by Type (2017-2028)
  • Figure 50. Middle East and Africa Endocrine Testing Market Size Market Share by Application (2017-2028)
  • Figure 51. Middle East and Africa Endocrine Testing Market Size Share by Country (2017-2028)
  • Figure 52. Turkey Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Saudi Arabia Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. UAE Endocrine Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Abbott Laboratories Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 56. AdnaGen Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 57. Beckman Coulter/Danaher Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 58. Biomedical Diagnostics Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 59. BioMerieux Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 60. Bio-Rad Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 61. Dako Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 62. DiaSorin Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 63. Eiken Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 64. Fujirebio Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 65. Instrumentation Laboratory Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 66. Kyowa Medex Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 67. Matritech Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 68. Ortho-Clinical Diagnostics Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 69. Roche Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 70. Siemens Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 71. Sysmex Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 72. Thermo Fisher Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 73. Tosoh Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 74. Wako Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 75. Wallac/PE Revenue Growth Rate in Endocrine Testing Business (2017-2022)
  • Figure 76. Bottom-up and Top-down Approaches for This Report
  • Figure 77. Data Triangulation
  • Figure 78. Key Executives Interviewed
目次

This research report focuses on the Endocrine Testing Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Endocrine Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Tandem Mass Spectrometry
    • 1.2.3 Immunoassay
  • 1.3 Market by Application
    • 1.3.1 Global Endocrine Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Commercial Laboratories
    • 1.3.4 Ambulatory Care Centres
    • 1.3.5 Other Setting
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Endocrine Testing Market Perspective (2017-2028)
  • 2.2 Endocrine Testing Growth Trends by Region
    • 2.2.1 Endocrine Testing Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Endocrine Testing Historic Market Size by Region (2017-2022)
    • 2.2.3 Endocrine Testing Forecasted Market Size by Region (2023-2028)
  • 2.3 Endocrine Testing Market Dynamics
    • 2.3.1 Endocrine Testing Industry Trends
    • 2.3.2 Endocrine Testing Market Drivers
    • 2.3.3 Endocrine Testing Market Challenges
    • 2.3.4 Endocrine Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Endocrine Testing Players by Revenue
    • 3.1.1 Global Top Endocrine Testing Players by Revenue (2017-2022)
    • 3.1.2 Global Endocrine Testing Revenue Market Share by Players (2017-2022)
  • 3.2 Global Endocrine Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Endocrine Testing Revenue
  • 3.4 Global Endocrine Testing Market Concentration Ratio
    • 3.4.1 Global Endocrine Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Endocrine Testing Revenue in 2021
  • 3.5 Endocrine Testing Key Players Head office and Area Served
  • 3.6 Key Players Endocrine Testing Product Solution and Service
  • 3.7 Date of Enter into Endocrine Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Endocrine Testing Breakdown Data by Type

  • 4.1 Global Endocrine Testing Historic Market Size by Type (2017-2022)
  • 4.2 Global Endocrine Testing Forecasted Market Size by Type (2023-2028)

5 Endocrine Testing Breakdown Data by Application

  • 5.1 Global Endocrine Testing Historic Market Size by Application (2017-2022)
  • 5.2 Global Endocrine Testing Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Endocrine Testing Market Size (2017-2028)
  • 6.2 North America Endocrine Testing Market Size by Type
    • 6.2.1 North America Endocrine Testing Market Size by Type (2017-2022)
    • 6.2.2 North America Endocrine Testing Market Size by Type (2023-2028)
    • 6.2.3 North America Endocrine Testing Market Share by Type (2017-2028)
  • 6.3 North America Endocrine Testing Market Size by Application
    • 6.3.1 North America Endocrine Testing Market Size by Application (2017-2022)
    • 6.3.2 North America Endocrine Testing Market Size by Application (2023-2028)
    • 6.3.3 North America Endocrine Testing Market Share by Application (2017-2028)
  • 6.4 North America Endocrine Testing Market Size by Country
    • 6.4.1 North America Endocrine Testing Market Size by Country (2017-2022)
    • 6.4.2 North America Endocrine Testing Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Endocrine Testing Market Size (2017-2028)
  • 7.2 Europe Endocrine Testing Market Size by Type
    • 7.2.1 Europe Endocrine Testing Market Size by Type (2017-2022)
    • 7.2.2 Europe Endocrine Testing Market Size by Type (2023-2028)
    • 7.2.3 Europe Endocrine Testing Market Share by Type (2017-2028)
  • 7.3 Europe Endocrine Testing Market Size by Application
    • 7.3.1 Europe Endocrine Testing Market Size by Application (2017-2022)
    • 7.3.2 Europe Endocrine Testing Market Size by Application (2023-2028)
    • 7.3.3 Europe Endocrine Testing Market Share by Application (2017-2028)
  • 7.4 Europe Endocrine Testing Market Size by Country
    • 7.4.1 Europe Endocrine Testing Market Size by Country (2017-2022)
    • 7.4.2 Europe Endocrine Testing Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Endocrine Testing Market Size (2017-2028)
  • 8.2 Asia-Pacific Endocrine Testing Market Size by Type
    • 8.2.1 Asia-Pacific Endocrine Testing Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Endocrine Testing Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Endocrine Testing Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Endocrine Testing Market Size by Application
    • 8.3.1 Asia-Pacific Endocrine Testing Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Endocrine Testing Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Endocrine Testing Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Endocrine Testing Market Size by Region
    • 8.4.1 Asia-Pacific Endocrine Testing Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Endocrine Testing Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Endocrine Testing Market Size (2017-2028)
  • 9.2 Latin America Endocrine Testing Market Size by Type
    • 9.2.1 Latin America Endocrine Testing Market Size by Type (2017-2022)
    • 9.2.2 Latin America Endocrine Testing Market Size by Type (2023-2028)
    • 9.2.3 Latin America Endocrine Testing Market Share by Type (2017-2028)
  • 9.3 Latin America Endocrine Testing Market Size by Application
    • 9.3.1 Latin America Endocrine Testing Market Size by Application (2017-2022)
    • 9.3.2 Latin America Endocrine Testing Market Size by Application (2023-2028)
    • 9.3.3 Latin America Endocrine Testing Market Share by Application (2017-2028)
  • 9.4 Latin America Endocrine Testing Market Size by Country
    • 9.4.1 Latin America Endocrine Testing Market Size by Country (2017-2022)
    • 9.4.2 Latin America Endocrine Testing Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Endocrine Testing Market Size (2017-2028)
  • 10.2 Middle East & Africa Endocrine Testing Market Size by Type
    • 10.2.1 Middle East & Africa Endocrine Testing Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Endocrine Testing Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Endocrine Testing Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Endocrine Testing Market Size by Application
    • 10.3.1 Middle East & Africa Endocrine Testing Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Endocrine Testing Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Endocrine Testing Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Endocrine Testing Market Size by Country
    • 10.4.1 Middle East & Africa Endocrine Testing Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Endocrine Testing Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Endocrine Testing Introduction
    • 11.1.4 Abbott Laboratories Revenue in Endocrine Testing Business (2017-2022)
    • 11.1.5 Abbott Laboratories Recent Developments
  • 11.2 AdnaGen
    • 11.2.1 AdnaGen Company Details
    • 11.2.2 AdnaGen Business Overview
    • 11.2.3 AdnaGen Endocrine Testing Introduction
    • 11.2.4 AdnaGen Revenue in Endocrine Testing Business (2017-2022)
    • 11.2.5 AdnaGen Recent Developments
  • 11.3 Beckman Coulter/Danaher
    • 11.3.1 Beckman Coulter/Danaher Company Details
    • 11.3.2 Beckman Coulter/Danaher Business Overview
    • 11.3.3 Beckman Coulter/Danaher Endocrine Testing Introduction
    • 11.3.4 Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2017-2022)
    • 11.3.5 Beckman Coulter/Danaher Recent Developments
  • 11.4 Biomedical Diagnostics
    • 11.4.1 Biomedical Diagnostics Company Details
    • 11.4.2 Biomedical Diagnostics Business Overview
    • 11.4.3 Biomedical Diagnostics Endocrine Testing Introduction
    • 11.4.4 Biomedical Diagnostics Revenue in Endocrine Testing Business (2017-2022)
    • 11.4.5 Biomedical Diagnostics Recent Developments
  • 11.5 BioMerieux
    • 11.5.1 BioMerieux Company Details
    • 11.5.2 BioMerieux Business Overview
    • 11.5.3 BioMerieux Endocrine Testing Introduction
    • 11.5.4 BioMerieux Revenue in Endocrine Testing Business (2017-2022)
    • 11.5.5 BioMerieux Recent Developments
  • 11.6 Bio-Rad
    • 11.6.1 Bio-Rad Company Details
    • 11.6.2 Bio-Rad Business Overview
    • 11.6.3 Bio-Rad Endocrine Testing Introduction
    • 11.6.4 Bio-Rad Revenue in Endocrine Testing Business (2017-2022)
    • 11.6.5 Bio-Rad Recent Developments
  • 11.7 Dako
    • 11.7.1 Dako Company Details
    • 11.7.2 Dako Business Overview
    • 11.7.3 Dako Endocrine Testing Introduction
    • 11.7.4 Dako Revenue in Endocrine Testing Business (2017-2022)
    • 11.7.5 Dako Recent Developments
  • 11.8 DiaSorin
    • 11.8.1 DiaSorin Company Details
    • 11.8.2 DiaSorin Business Overview
    • 11.8.3 DiaSorin Endocrine Testing Introduction
    • 11.8.4 DiaSorin Revenue in Endocrine Testing Business (2017-2022)
    • 11.8.5 DiaSorin Recent Developments
  • 11.9 Eiken
    • 11.9.1 Eiken Company Details
    • 11.9.2 Eiken Business Overview
    • 11.9.3 Eiken Endocrine Testing Introduction
    • 11.9.4 Eiken Revenue in Endocrine Testing Business (2017-2022)
    • 11.9.5 Eiken Recent Developments
  • 11.10 Fujirebio
    • 11.10.1 Fujirebio Company Details
    • 11.10.2 Fujirebio Business Overview
    • 11.10.3 Fujirebio Endocrine Testing Introduction
    • 11.10.4 Fujirebio Revenue in Endocrine Testing Business (2017-2022)
    • 11.10.5 Fujirebio Recent Developments
  • 11.11 Instrumentation Laboratory
    • 11.11.1 Instrumentation Laboratory Company Details
    • 11.11.2 Instrumentation Laboratory Business Overview
    • 11.11.3 Instrumentation Laboratory Endocrine Testing Introduction
    • 11.11.4 Instrumentation Laboratory Revenue in Endocrine Testing Business (2017-2022)
    • 11.11.5 Instrumentation Laboratory Recent Developments
  • 11.12 Kyowa Medex
    • 11.12.1 Kyowa Medex Company Details
    • 11.12.2 Kyowa Medex Business Overview
    • 11.12.3 Kyowa Medex Endocrine Testing Introduction
    • 11.12.4 Kyowa Medex Revenue in Endocrine Testing Business (2017-2022)
    • 11.12.5 Kyowa Medex Recent Developments
  • 11.13 Matritech
    • 11.13.1 Matritech Company Details
    • 11.13.2 Matritech Business Overview
    • 11.13.3 Matritech Endocrine Testing Introduction
    • 11.13.4 Matritech Revenue in Endocrine Testing Business (2017-2022)
    • 11.13.5 Matritech Recent Developments
  • 11.14 Ortho-Clinical Diagnostics
    • 11.14.1 Ortho-Clinical Diagnostics Company Details
    • 11.14.2 Ortho-Clinical Diagnostics Business Overview
    • 11.14.3 Ortho-Clinical Diagnostics Endocrine Testing Introduction
    • 11.14.4 Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2017-2022)
    • 11.14.5 Ortho-Clinical Diagnostics Recent Developments
  • 11.15 Roche
    • 11.15.1 Roche Company Details
    • 11.15.2 Roche Business Overview
    • 11.15.3 Roche Endocrine Testing Introduction
    • 11.15.4 Roche Revenue in Endocrine Testing Business (2017-2022)
    • 11.15.5 Roche Recent Developments
  • 11.16 Siemens
    • 11.16.1 Siemens Company Details
    • 11.16.2 Siemens Business Overview
    • 11.16.3 Siemens Endocrine Testing Introduction
    • 11.16.4 Siemens Revenue in Endocrine Testing Business (2017-2022)
    • 11.16.5 Siemens Recent Developments
  • 11.17 Sysmex
    • 11.17.1 Sysmex Company Details
    • 11.17.2 Sysmex Business Overview
    • 11.17.3 Sysmex Endocrine Testing Introduction
    • 11.17.4 Sysmex Revenue in Endocrine Testing Business (2017-2022)
    • 11.17.5 Sysmex Recent Developments
  • 11.18 Thermo Fisher
    • 11.18.1 Thermo Fisher Company Details
    • 11.18.2 Thermo Fisher Business Overview
    • 11.18.3 Thermo Fisher Endocrine Testing Introduction
    • 11.18.4 Thermo Fisher Revenue in Endocrine Testing Business (2017-2022)
    • 11.18.5 Thermo Fisher Recent Developments
  • 11.19 Tosoh
    • 11.19.1 Tosoh Company Details
    • 11.19.2 Tosoh Business Overview
    • 11.19.3 Tosoh Endocrine Testing Introduction
    • 11.19.4 Tosoh Revenue in Endocrine Testing Business (2017-2022)
    • 11.19.5 Tosoh Recent Developments
  • 11.20 Wako
    • 11.20.1 Wako Company Details
    • 11.20.2 Wako Business Overview
    • 11.20.3 Wako Endocrine Testing Introduction
    • 11.20.4 Wako Revenue in Endocrine Testing Business (2017-2022)
    • 11.20.5 Wako Recent Developments
  • 11.21 Wallac/PE
    • 11.21.1 Wallac/PE Company Details
    • 11.21.2 Wallac/PE Business Overview
    • 11.21.3 Wallac/PE Endocrine Testing Introduction
    • 11.21.4 Wallac/PE Revenue in Endocrine Testing Business (2017-2022)
    • 11.21.5 Wallac/PE Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer